Goldfaden D, Orringer M B, Appelman H D, Kalish R
J Thorac Cardiovasc Surg. 1986 Feb;91(2):242-7.
Between 1965 and 1984, 72 patients underwent operation for adenocarcinoma of the distal esophagus or gastric cardia. A standard transthoracic esophagogastrectomy and esophagogastrostomy was performed in 43 and a transhiatal esophagectomy without thoracotomy and partial proximal gastrectomy was performed in 29. There was no significant difference between the two groups in age, sex, or TNM tumor staging. The perioperative complication rate was 86% in the esophagogastrectomy patients and 48% in the transhiatal esophagectomy patients (p less than 0.05). Mortality was higher in the esophagogastrectomy group (14%) than in the transhiatal esophagectomy group (7%). Average operative blood loss was greater in the esophagogastrectomy patients (2,510 versus 1,187 ml). Average postoperative hospitalization was longer for the esophagogastrectomy patients (22.2 days versus 12.3 days). Both differences are statistically significant (p less than 0.05). Late results, as evaluated by life-table analysis, showed no significant difference in survival between the two groups of patients. Because the morbidity and mortality rates of transhiatal esophagectomy are as low as or lower than those for esophagogastrectomy, late survival is as good, and palliation is superior (less suture-line tumor recurrence and reflux esophagitis), we believe that transhiatal esophagectomy is the preferred operative approach in patients with adenocarcinoma of the distal esophagus or gastric cardia.
1965年至1984年间,72例患者接受了远端食管癌或贲门癌手术。43例行标准经胸食管胃切除术及食管胃吻合术,29例行经裂孔食管切除术(不开胸)及部分近端胃切除术。两组患者在年龄、性别或TNM肿瘤分期方面无显著差异。食管胃切除术患者围手术期并发症发生率为86%,经裂孔食管切除术患者为48%(p<0.05)。食管胃切除术组死亡率(14%)高于经裂孔食管切除术组(7%)。食管胃切除术患者平均术中失血量更多(2510 ml对1187 ml)。食管胃切除术患者术后平均住院时间更长(22.2天对12.3天)。这两个差异均具有统计学意义(p<0.05)。通过寿命表分析评估的远期结果显示,两组患者生存率无显著差异。由于经裂孔食管切除术的发病率和死亡率与食管胃切除术相当或更低,远期生存率良好,且缓解效果更佳(缝线处肿瘤复发和反流性食管炎较少),我们认为经裂孔食管切除术是远端食管癌或贲门癌患者首选的手术方式。